ORTTime news for many women with breast cancer. There Endoscopic Mastectomy It is a surgical technique less invasive compared to the conventional one and is associated with minor post-operative complications, Less visible scars. But not only. In most cases, it is possible to proceed with a immediate breast reconstruction. These are the good news announced today, Tuesday 5 August, following an international meta-analysis, the widest conduct so far on the topic. The study, published in the magazine British Journal of Surgery – Openwas coordinated by the‘IRCCS of Candiolo And he involved over 2,600 patients in Europe, Asia and North America.
Breast cancer: mastectomy with savings of the nipple
There Mastectomy with savings of the nipple (NSM-Nipple-SPARING MASTECTOMY) today represents one of the Surgical options more adopted for the treatment of breast cancer and prophylactic surgery in patients with high genetic riskthanks to the possibility of Store the Areola-Capezzolo complex. However, in its traditional form it can lead to the appearance of visible scars and, in some cases, complications such as the necrosis of the Areola-Capezzolo complex, due to an insufficient blood supply.
The advantages of endoscopic mastectomy
“Endoscopic mastectomy was created to overcome these limits,” explains Dr. Antonio Toesca, director of the breast surgery of the IRCCS of Candiolo (Turin), who led the research group. «By moving theengraving in less exposed areas, such as the armpitit is possible to avoid scars on the breast and reduce the aesthetic and functional impact of the intervention, while maintaining oncological efficacy ».
The analysis of the data collected confirmed that endoscopic mastectomy is associated with one 20% reduction in post-operative pain and complications -in particular of the necrosis of the Areola-Capezzolo complex-compared to the conventional technique. Furthermore, it allowed, in almost all cases, one immediate breast reconstructionwith a success rate comparable to that of standard surgery.
A single incision under the armpit
“In particular, the intervention performed through a single engraving in the axillary region has proven more respectful of anatomy and skin sensitivity, with a positive impact on the quality of life of patients – adds Toesca -. The only one disadvantage found is a slightly longer operating time». The research group underlines that the Oncological safety of the technique It was comparable to that of traditional surgery in terms of local control of the disease and recurrence rates, even with the advantage of a less invasive approach From a physical and psychological point of view.
For selected cases of breast cancer
«Endoscopic mastectomy is therefore configured as one valid option for selected patients, provided it comes performed in centers with specific experience and as part of a multidisciplinary path -concludes Toesca -. Further studies with long-term follow-ups and standardized protocols will be needed to confirm these results and evaluate their lasting impact on survival and quality of life ».
«This study reflects the commitment of the IRCCS of Candiolo in advanced clinical research, at the service of a increasingly personalized oncological surgery It is attentive to the overall well -being of patients “, concludes Salvatore Nieddu, general manager of the institute.
What to know about the IRCCS Candiolo
THE’IRCCS Candiolo It is an oncological center of excellence located At the gates of Turin which unites in a single structure scientific research, diagnosis and care.
Inaugurated in 1996 thanks to the support of the Piedmontese Foundation for Cancer Research And to the contribution of the Piedmont Region, it is the first IRCCS (Institute of research and scientific care) oncological nature of Piedmont recognized by the Ministry of Health and is part of the Oncological Network of Piedmont-Valle d’Aosta. In 2022 it was certified byEuropean Organization of Cancer Institutes (Oeci) How Comprehensive Cancer Centeror High specialization research and care center which offers a multidisciplinary approach and integrated to assistance of the patient, from diagnosis to therapy, to psychological support. Each year he welcomes over 35,000 patients both in the day hospital regime and hospitalization.
IRCCS CANDIOLO collaborates with the University of Turin and with important scientific institutions at national and international level in areas such as i Breast tumors and ovary, chest-spine and urological tumors, gastrointestinal and hepatobiliary, oncohematological, sarcomas and rare tumors, skin neoplasms and cervic-cephalic.
At Irccs Candiolo, research is the engine of progress in the fight against cancer. With about 40 workshops, the Institute adopts a translational approach, which integrates scientific and technological innovation with clinical practice, transforming the discoveries into increasingly effective and personalized therapies. Doctors and researchers work side by side on avant-garde projects ranging from early diagnosis to immuno-oncology, from tumor genetics to the development of cellular and targeted therapies using vital models such as tumor organoids. In addition, the IRCCS of Candiolo is Patient recruitment center for participation in national and international clinical trials. A constant commitment to offer patients increasingly advanced and personalized.